Skip to content

ICP Versus Intracranial Compliance Guided Management in SAH

Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00248690
Enrollment
100
Registered
2005-11-04
Start date
2005-11-30
Completion date
2009-06-30
Last updated
2011-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid Hemorrhage (SAH)

Keywords

Subarachnoid hemorrhage, Intracranial hypertension, Intracranial pressure, Diagnostic techniques and procedures, Compliance, Treatment outcome, Intensive care, surgical

Brief summary

The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.

Detailed description

In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months.

Interventions

DEVICEICP mean wave amplitude

Appropriate measures when ICP mean wave amplitude is to high, e.g. CSF drainage

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subarachnoid hemorrhage, acute * Intracerebral pressure monitoring device inserted

Exclusion criteria

* No intracranial pressure monitoring * Age \< 18 years

Design outcomes

Primary

MeasureTime frame
All cause mortality and neurological outcome3 and 12 months

Secondary

MeasureTime frame
Length of stay (ICU, hospital); complications; effect of treatment modalities on mean ICP, CPP, ICP mean wave amplitude.Hospital stay

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026